Xylem (NYSE: XYL) reported Q4 EPS of $0.66, $0.01 better than the analyst estimate of $0.65. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.13 billion.

GUIDANCE:

Xylem sees FY2017 EPS of $2.20-$2.35, versus the consensus of $2.29. Xylem sees FY2017 revenue of $4.5-4.6 billion, versus the consensus of $4.63 billion.

For earnings history and earnings-related data on Xylem (XYL) click here.